Ernexa Therapeutics Inc.
ERNA
Revenue
1.00k
▼-486.00k▼-99.79%
3 Months ChangeAssets
6.17M
▼-1.41M▼-18.62%
3 Months ChangeLiabilities
2.60M
▼-538.00k▼-17.13%
3 Months ChangeFree Cash Flow
-3.85M
▲2.20M▲36.39%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-26
Form 8-K
ID: 0001493152-26-008182
2026-02-11
Form 8-K
ID: 0001493152-26-006227
2025-12-11
Form 8-K
ID: 0001493152-25-027167
2025-11-07
Form 10-Q
ID: 0001493152-25-021287
2025-08-13
Form 10-Q
ID: 0001493152-25-011910
2025-07-07
Form 8-K
ID: 0001641172-25-018009
2025-06-12
Form 8-K
ID: 0001641172-25-014877
2025-06-09
Form 8-K
ID: 0001641172-25-014318
2025-06-02
Form 8-K
ID: 0001641172-25-013249
2025-05-07
Form 10-Q
ID: 0001641172-25-009044